Oklahoma Senate Bill SB807

Oklahoma 2026 Regular Session

• Introduced: 2/3/25
• Refer: 2/4/25

Caption

Health care; creating the Vaccine Transparency and Informed Consent Act; requiring certain informed consent; providing certain penalties and remedies. Effective date.

Summary

SB 807 would create the “Vaccine Transparency and Informed Consent Act” in Oklahoma law and require health care providers to give patients a detailed written disclosure before administering any vaccine. The required document would have to list vaccine ingredients, summarize testing and development, describe known and potential risks from clinical trials and post-market surveillance, identify certain ethical considerations in development or production, explain available exemptions under state law, and provide information about the National Vaccine Injury Compensation Program. The bill also requires the document to state that the patient may accept, decline, or defer the vaccine. The bill further requires providers to obtain written informed consent before vaccination, including acknowledgment that the patient received and understood the materials, had an opportunity to ask questions, and made a voluntary decision. Providers must keep signed consent forms in the medical record for at least seven years. The measure would take effect November 1, 2025.

Impact

If enacted, SB 807 would add new sections to Title 63 of the Oklahoma Statutes governing vaccine disclosure and consent practices. It would impose affirmative documentation and consent duties on health care providers and institutions, create administrative penalties for noncompliance, authorize licensing-board discipline for repeat violations, and allow patients to file complaints or pursue civil damages. The bill also expressly treats the records as confidential under HIPAA and other privacy laws.

Sentiment

No committee transcript or recorded vote information was provided, so there is no direct evidence of debate or formal support/opposition in the available materials. Based on the bill text, the measure appears framed around patient autonomy, transparency, and informed consent in vaccination decisions. The absence of voting history or discussion prevents a reliable assessment of broader legislative sentiment.

Contention

The likely points of contention are the scope and burden of the required disclosures, especially the mandate to provide extensive ingredient, safety, ethical, and compensation-program information before every vaccination. Health care providers and public health advocates may view the requirements as administratively burdensome or as potentially discouraging vaccination, while supporters would likely argue the bill strengthens informed consent and patient choice. The bill’s inclusion of VAERS data, fetal tissue and animal-derived component disclosures, and explicit references to exemptions and injury claims suggests it is designed to address concerns often raised by vaccine-skeptical constituents.